BioCentury
ARTICLE | Company News

Bayer invests $85 million in CuraGen

February 22, 2001 8:00 AM UTC

CRGN received an $85 million equity investment from Bayer (DAX:BAYG) following FTC clearance of the companies' two genomics agreements. Under the agreements, CRGN will provide 80 small molecule target...